Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare
Fennec Pharmaceuticals Inc. Operating Income 2011–2025
Fennec Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Fennec Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -119000, a 85.27% decrease year-over-year.
- Fennec Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -3.8 M, a 254.85% decrease year-over-year.
- Fennec Pharmaceuticals Inc. annual operating income for 2025 was -6.3 M, a 344.63% decrease from 2024.
- Fennec Pharmaceuticals Inc. annual operating income for 2024 was 2.6 M, a 120.11% decrease from 2023.
- Fennec Pharmaceuticals Inc. annual operating income for 2023 was -12.8 M, a 43.46% decrease from 2022.
- Fennec Pharmaceuticals Inc. annual operating income for 2022 was -22.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fennec Pharmaceuticals Inc. Operating Income — FAQ
Fennec Pharmaceuticals Inc. (FENC) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Fennec Pharmaceuticals Inc.'s operating income?
Fennec Pharmaceuticals Inc. (FENC) reported operating income of -$6M for fiscal 2025.
Where can I see FENC's operating income history?
The chart and table above show Fennec Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.